According to a newly published market research report by 24LifeSciences, global biomonitoring and bioburden testing market was valued at USD 3.5 billion in 2024 and is projected to reach USD 6.2 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period 2025-2031.
Biomonitoring involves the measurement of toxic substances in biological specimens, while...
In the highly regulated world of pharmaceutical and medical device manufacturing, safety is not just a goal it is a mandatory requirement. As production volumes increase and product complexity grows, the demand for Bioburden Testing Market is reaching unprecedented levels. This testing, which quantifies the microbial population on a product before its final sterilization, has become the "gold...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek